Clinical Trial Update: PBMC as Biomarkers of Diabetic Cardiomyopathy

View source ↗

Summary

A clinical trial is evaluating peripheral blood mononuclear cells as biomarkers for diabetic cardiomyopathy and related heart failure conditions; the study is s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Mildly Reduced Ejection Fraction
• Heart Failure with Preserved Ejection Fraction
• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Type 2 Diabetes, Metabolic Syndrome | Status: RECRUITING